BiotechTube
Home/NanoMosaic/Philippe Mourere
PM

Philippe Mourere

Chief Executive Officer & VP of Software Development

NanoMosaic

Therapeutic Areas

NeurologyGene Therapy

NanoMosaic Pipeline

DrugIndicationPhase
AAV Gene Therapy QCAAV capsid and transgene characterizationCommercial (RUO)
Blood pTau DetectionAlzheimer's Disease and Related DementiasDevelopment

Leadership Team at NanoMosaic

DQ
Dr. Qimin Quan
Co-Founder & Chief Scientific Officer
JB
John Boyce
Co-Founder (Managing Director, TigerGene Ventures)
View full NanoMosaic profile